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ABSTRACT
Kyoto Encyclopedia of Genes and Genomes (KEGG,
http://www.genome.jp/kegg/ or http://www.kegg
.jp/) is a database resource that integrates
genomic, chemical and systemic functional informa-
tion. In particular, gene catalogs from completely
sequenced genomes are linked to higher-level
systemic functions of the cell, the organism and
the ecosystem. Major efforts have been undertaken
to manually create a knowledge base for such
systemic functions by capturing and organizing ex-
perimental knowledge in computable forms; namely,
in the forms of KEGG pathway maps, BRITE func-
tional hierarchies and KEGG modules. Continuous
efforts have also been made to develop and
improve the cross-species annotation procedure
for linking genomes to the molecular networks
through the KEGG Orthology system. Here we
report KEGG Mapper, a collection of tools for
KEGG PATHWAY, BRITE and MODULE mapping,
enabling integration and interpretation of large-
scale data sets. We also report a variant of the
KEGG mapping procedure to extend the knowledge
base, where different types of data and knowledge,
such as disease genes and drug targets, are
integrated as part of the KEGG molecular
networks. Finally, we describe recent enhance-
ments to the KEGG content, especially the incorp-
oration of disease and drug information used in
practice and in society, to support translational
bioinformatics.
INTRODUCTION
The large-scale molecular data sets generated by genome
sequencing and other high-throughput experimental
technologies are the basis for understanding life as a mo-
lecular system and for developing practical applications in
medical, pharmaceutical and environmental sciences.
The key to linking such large-scale data sets to practical
values lies in bioinformatics technologies, not only in
terms of computational methods, but also in terms of
knowledge bases. Since 1995, we have been developing
Kyoto Encyclopedia of Genes and Genomes (KEGG), a
reference knowledge base for deciphering the genome.
Experimental knowledge on systemic functions of the
cell and the organism is represented in terms of molecular
networks (KEGG pathway maps, BRITE functional
hierarchies and KEGG modules), and a mechanism
(KEGG Orthology system) is developed for linking
genes in the genome to nodes of the molecular network.
Over the past 16 years, KEGG has been expanded signiﬁ-
cantly to meet the needs of both large projects and indi-
vidual laboratories. In recent years, our efforts have been
focused on capturing and representing knowledge on
diseases as perturbed states of the molecular network
and drugs as perturbants to the molecular network (1).
The scientists’ promises regarding the medical and
social beneﬁts of the Human Genome Project and subse-
quent projects appear to be long overdue, but thanks to
the advancement of next-generation sequencing techno-
logies the time may have ﬁnally come for bringing the
genomic revolution to society. To meet the needs of trans-
lational bioinformatics the KEGG resource is being
integrated with disease and drug information used in
clinical practice and in wider society, such as the
package inserts of marketed drugs. It is hoped that
KEGG will assist scientists to translate their research
results into medical and industrial innovations and will
also allow doctors, pharmacists, patients and consumers
to make better use of scientiﬁc data on disease and
drug-related molecular networks.
OVERVIEW OF KEGG
KEGG databases
KEGG is an integrated database resource consisting of the
15 main databases shown in Table 1. It covers various
data objects, called KEGG objects, for computer
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gorized into systems information (PATHWAY, BRITE,
MODULE, DISEASE, DRUG and ENVIRON),
genomic information (ORTHOLOGY, GENOME and
GENES) and chemical information (COMPOUND,
GLYCAN, REACTION, RPAIR, RCLASS and
ENZYME). The identiﬁer of each database entry is gen-
erally in the form of ‘db:entry’ where ‘db’ is the database
name and ‘entry’ is the entry name. However, ‘db’ may be
omitted in 13 of the listed databases, because the entry
name, called the KEGG object identiﬁer consisting of a
database-dependent preﬁx and a ﬁve-digit number, is
unique across the databases. These 13 databases are all
manually created by KEGG. The remaining two data-
bases, KEGG GENES derived from RefSeq (2) and
KEGG ENZYME derived from ExplorEnz (3), are also
given KEGG-original annotations. In the genomic infor-
mation category there are auxiliary databases that are
computationally generated, including KEGG DGENES
for genes in draft genomes, KEGG EGENES for genes
as EST contigs (4), newly introduced KEGG MGENES
for genes in metagenomes, and KEGG SSDB for sequence
similarity relationships among KEGG GENES (5).
KEGG organisms
KEGG GENES is a collection of gene catalogs for all
organisms whose genomes are completely sequenced and
made available by RefSeq. Each organism is treated like a
database with the three-letter organism code as the
database name and the gene identiﬁer (either NCBI
Gene ID or locus_tag) as the entry name. The three-letter
organism code is an alias of the T number identiﬁer in the
KEGG GENOME database; for example, ‘hsa’ for Homo
sapiens is equivalent to ‘T01001’ (Table 1). The organism
code is also used as a preﬁx to identify organism-speciﬁc
versions of KEGG pathway maps, BRITE hierarchies and
KEGG modules (see ‘KEGG Orthology’ section). The or-
ganisms of KEGG DGENES and EGENES may be
identiﬁed with the four-letter organism codes starting
with ‘d’ and ‘e’, respectively, or the T numbers. The
environmental samples of KEGG MGENES are identiﬁed
only by the T numbers.
KEGG pathway maps
The KEGG pathway maps are graphical diagrams repre-
senting knowledge on molecular interaction and reaction
networks for metabolism, genetic information processing,
environmental information processing, cellular processes,
organismal systems, human diseases and drug develop-
ment. Each map is manually drawn with in-house
software called KegSketch, summarizing experimental
evidence in published literature. Basic graphics objects in
the KEGG pathway maps are: (i) boxes for KEGG
Orthology (KO) groups identiﬁed by K numbers, (ii)
circles for small molecules identiﬁed by C numbers,
glycans identiﬁed by G numbers, and other molecules,
and (iii) lines for KO groups in global metabolism maps.
Boxes in regular metabolic maps and lines in global meta-
bolic maps, both for KO groups, are also linked to
enzymes identiﬁed by EC numbers and reactions identiﬁed
by R numbers. The reference pathway map identiﬁed with
preﬁx ‘map’ contains all three, and the separate version of
the reference pathway map is identiﬁed with preﬁx ‘ko’,
‘ec’, or ‘rn’ (Tables 1 and 2).
BRITE functional hierarchies
The BRITE hierarchy ﬁles, called the htext (hierarchical
text) ﬁles, represent known functional hierarchies (hier-
archical classiﬁcations) of genes and proteins, diseases
and drugs, compounds and reactions, and organisms
and cells. Each htext ﬁle is manually created with
in-house software called KegHierEditor. It contains ‘A’,
‘B’, ‘C’, etc. at the ﬁrst column to indicate the hierarchy
level and may contain multiple tab-delimited columns.
Thus, the htext ﬁle is like an Excel ﬁle with an additional
ﬁrst column for the hierarchy level. There are two classes
of BRITE htext ﬁles (Tables 1 and 2). Those identiﬁed
with preﬁx ‘ko’ are for gene and protein classiﬁcations
represented by KO groups (K numbers), and those
identiﬁed with preﬁx ‘br’ (or Japanese version ‘jp’) are
Table 1. KEGG databases and KEGG object identiﬁers
Category Database Content Preﬁx Example
Systems information KEGG PATHWAY Pathway maps map, ko, ec, rn, (org) hsa04930
KEGG BRITE Functional hierarchies br, jp, ko, (org) ko01003
KEGG MODULE KEGG modules M, (org)_M M00008
KEGG DISEASE Human diseases H H00004
KEGG DRUG Drugs D D01441
KEGG ENVIRON Crude drugs, etc. E E00048
Genomic information KEGG ORTHOLOGY KO groups K K04527
KEGG GENOME KEGG organisms T T01001 (hsa)
KEGG GENES Genes in high-quality genomes hsa:3634
Chemical information KEGG COMPOUND Metabolites and other small molecules C C00031
KEGG GLYCAN Glycans G G00109
KEGG REACTION Biochemical reactions R R00259
KEGG RPAIR Reactant pairs RP RP04458
KEGG RCLASS Reaction class RC RC00046
KEGG ENZYME Enzyme nomenclature ec:2.7.10.1
‘(org)’ represents three-, four- or ﬁve-letter organism code.
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drugs (D numbers) and compounds (C numbers).
KEGG modules
KEGG MODULE was originally introduced to deﬁne
tighter functional units than KEGG PATHWAY (6)s o
that the pathway information in KEGG would be repre-
sented in three resolutions: global maps (for metabolism),
regular maps and modules. Subsequently, the scope of
KEGG MODULE has been extended and there are cur-
rently four types of KEGG modules: (i) pathway modules,
(ii) structural complexes, (iii) functional sets and (iv) sig-
nature modules. The ﬁrst three types of modules usually
correspond to parts of KEGG pathway maps and BRITE
hierarchies. The signature module is a set of genes in the
genome, or perhaps in the transcriptome as well, that can
be used as a marker for the phenotype, such as pathogen-
icity and metabolic capacity. Each KEGG module is
deﬁned by the combination of K numbers and associated
with an automatically generated module map according to
the predeﬁned notations: space delimited items for
pathway elements, comma separated items in parentheses
for alternatives, plus sign to deﬁne a complex and minus
sign for an optional item.
KEGG Orthology
The KEGG pathway maps, BRITE functional hierarchies
and KEGG modules are created in a general way to be
applicable to all organisms; namely, in terms of the KO
groups rather than individual gene names in speciﬁc or-
ganisms. Each KO entry represents a manually deﬁned
and context-dependent ortholog group that generally cor-
responds to a node of the pathway map, BRITE hierarchy
or KEGG module, and which consists of orthologous
genes in all available genomes assigned by the genome
annotation procedure described below. Thus, the
organism-speciﬁc versions of pathway maps, BRITE
hierarchies and KEGG modules can be automatically
generated by converting K number nodes to gene identiﬁer
nodes as well as by coloring in green (which is a KEGG
convention). The organism-speciﬁc version is identiﬁed by
using the organism code in place of ‘ko’ as a preﬁx in
PATHWAY and BRITE, and in addition to the M
number preﬁx in MODULE as shown in Table 2.
Genome annotation in KEGG
The genome annotation in KEGG is essentially
cross-species annotation, ﬁnding orthologous genes in all
available genomes for given K numbers, and is currently
performed as follows. (i) Experimental evidence on known
functions of genes and proteins is organized in the
KO database, which is created together with the KEGG
PATHWAY, BRITE and MODULE databases. (ii) Gene
catalogs of complete genomes are generated from RefSeq
and other public resources. (iii) All pairs of genomes (gene
catalogs) are compared by the SSEARCH program, and
the GFIT tables are generated detailing the information
for each gene in a genome about best-hit genes in all other
genomes (5). (iv) GFIT tables are continuously updated,
and the automatic version of the KOALA tool (1) presents
to human annotators a summary of discrepancies between
its K number assignment and the current annotation.
(v) Discrepancies are examined by annotators with the
manual version of KOALA and other tools such as for
protein domains, ortholog tables and gene clusters. We
plan to incorporate KEGG modules into the KOALA
annotation procedure.
NEW FEATURES OF KEGG
KEGG Mapper
KEGG PATHWAY, KEGG BRITE and KEGG
MODULE constitute the KEGG reference knowledge
base for biological interpretation of molecular data sets,
especially large-scale data sets generated by high-
throughput experimental technologies. This is accom-
plished by the process of KEGG mapping, which is to
map, for example, a genomic content of genes to
generate organism-speciﬁc versions of pathways as men-
tioned above or a transcriptomic content of genes to see
which parts of pathways are up/down regulated. The
mapping process is considered a set operation between
the query data set and the target data of the KEGG ref-
erence knowledge base.
KEGG Mapper is the user interface for KEGG
mapping. It currently consists of seven tools as shown in
Table 3. For the three basic tools (Search Pathway, Search
Brite and Search Module) the query data set is a collection
of molecular objects (genes, proteins, small molecules,
Table 2. Naming convention of KEGG molecular networks
Molecular network Manually created Computationally generated
Reference Organism-speciﬁc Disease/drug Other
Metabolic pathway map00010 ko00010 hsa00010 hsadd00010
ec00010
rn00010
Non-metabolic pathway map02010 ko02010 hsa02010 hsadd02010
Gene/protein brite ko02000 hsa02000 hsa02000_dd
Non-gene/protein brite br08303 br08303_target
br08303_enzyme
Module M00001 hsa_M00001
Five-digit numbers are examples only.
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absence of objects, resulting in pathway and ontology en-
richment. In the advanced tools (Search&Color Pathway,
Search&Color Brite, Color Pathway and Join Brite)
the query data can consist of molecular objects and their
attributes; for example, genes with up/down expression
levels and genes with disease names known to be
associated. The attributes need to be processed and
color-coded when using the Search&Color Pathway and
Search&Color Brite tools. The Color Pathway tool
accepts numerical values, which may be displayed by
color shading or by overlaying 3D bar graphs on top of
the KEGG pathway map. Figure 1 shows an example of
the latter type of display, where genes in a cancer pathway
are associated with somatic mutation frequency. The Join
Brite tool accepts any text information and returns the
result by adding a column or another hierarchy level in
the BRITE hierarchy ﬁle (see: Knowledge base extension).
Genome comparison and combination
For the organisms (GENES, DGENES and EGENES)
and environmental samples (MGENES) available in
KEGG, it is now possible to map multiple data sets
against KEGG pathway maps and BRITE functional
hierarchies. The user interface may be found in the
KEGG GENOME page, and the result is displayed
using multiple color coding. This feature can be used,
for example, to compare metabolic capabilities of different
organisms (see Figure 2 for human and Escherichia coli
comparison), to examine complementarity of host–
symbiont, host–pathogen and host–microbiome relation-
ships, and to examine collective features of pangenomes.
These tasks may be applied to the user’s own genomes by
using KEGG Mapper with preprocessing of K number
assignment and color speciﬁcation.
Knowledge base extension
The query data in KEGG Mapper is usually raw and un-
interpreted data, but the KEGG mapping set operation
may also be applied to well curated data sets. In fact it was
the original concept of the KEGG project to automatic-
ally generate organism-speciﬁc pathways through the set
operation between manually annotated genome data and
manually created pathway maps. We have extended this
approach as more data on diseases and drugs are
accumulated in KEGG, effectively enhancing the KEGG
knowledge base and enabling KEGG Mapper and other
applications to easily integrate disease and drug
information.
KEGG DRUG is a comprehensive collection of
approved drugs in Japan, USA and Europe uniﬁed
based on chemical structures and/or chemical compo-
nents. It contains rich information about molecular
networks (such as targets, metabolizing enzymes and
drug–drug interactions) enabling integrated analysis with
KEGG pathway maps and BRITE hierarchies. KEGG
DISEASE is still an underdeveloped database, but it
aims to computerize all human diseases with known
genetic factors and all infectious diseases with known
pathogen genomes, so that diseases can be analyzed as
perturbed states of the molecular networks.
The mapping of disease and drug data from these data-
bases is now incorporated in the daily KEGG update
procedure. First, all known disease genes accumulated
in KEGG DISEASE and all known drug targets
accumulated in KEGG DRUG are integrated in the
Figure 1. The Color Pathway tool in KEGG Mapper accepts numerical values associated with genes, which can be displayed by color-shading or 3D
mapping. Here somatic mutation frequency observed in chronic myeloid leukemia (obtained from the COSMIC database, http://www.sanger.ac.uk/
genetics/CGP/cosmic/) is shown on top of the global cancer pathway map (hsa05200).
Table 3. KEGG Mapper tools
Tool Query data Reference knowledge
Search Pathway Objects KEGG PATHWAY database
Search&Color
Pathway
Object–attributes
relations
KEGG PATHWAY database
Color Pathway Object–attributes
relations
KEGG PATHWAY map
Search Brite Objects KEGG BRITE database
Search&Color
Brite
Object–attributes
relations
KEGG BRITE database
Join Brite Object–attributes
relations
BRITE functional hierarchy
Search Module Objects KEGG MODULE database
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complished by preparing binary relations, human gene
identiﬁer to H number and human gene identiﬁer to D
number, as query data sets and applying the
Search&Color Pathway and Search&Color Brite tools.
The generated pathway maps and BRITE hierarchy ﬁles
are identiﬁed by the ‘hsadd’ preﬁx and the ‘_dd’ modiﬁer,
respectively, as shown in Table 2. The mapping result is
displayed by coloring: pink when the gene is associated
with a disease and light blue when the gene product is a
drug target. Figure 3 shows this disease/drug mapping
against the Alzheimer’s disease pathway map.
Second, drug targets, drug metabolizing enzymes and
other drug interaction data accumulated in KEGG
DRUG are mapped to selected BRITE hierarchy ﬁles by
the Join Brite tool. For example, drug targets and drug
metabolizing enzymes are mapped to the WHO’s ATC
(Anatomical Therapeutic Chemical) classiﬁcation, and
the generated versions, ‘br08303_target’ and ‘br08303_
enzyme’ (Table 2), contain additional information in
an additional column. The mapping result would allow
complementation of missing data and prediction of new
data, as similar chemical substances within this functional
hierarchy would have similar properties.
Translational bioinformatics
The KEGG mapping approach is being further expanded
to integrate disease and drug information used in practice
and in society, as well as related data contained in outside
resources. The Japanese version of the KEGG DRUG
database is already tightly integrated with the package
insert information of all prescription drugs and OTC
drugs marketed in Japan, provided by Japan
Pharmaceutical Information Center (JAPIC) and served
by GenomeNet (http://www.genome.jp/kusuri/). This
is reﬂected, for example, in the Japanese version of the
ATC classiﬁcation ﬁle, ‘jp08303_japic’, which contains
product names in an additional hierarchy level. A
similar integration will be performed for the drug
products marketed in USA and other countries.
Using the package inserts of all prescription drugs in
Japan, we extracted adverse drug–drug interactions from
the description of contraindications and warnings, con-
verted them into KEGG DRUG D number pairs and
tried to categorize interaction patterns, such as those
involving metabolizing enzymes or overlapping targets
(7). The DDI (drug–drug interaction) search based on
this data set is available in each KEGG DRUG entry
page, and the result may be displayed on top of the
ATC hierarchy.
While the main focus of the KEGG resource has been
the molecular network, the next step will have to include
the association of network states and phenotypic features,
such as network perturbations associated with diseases,
drug effects and other health conditions. The use of
controlled vocabulary to represent phenotypic features,
Figure 2. Comparison of metabolic pathways reconstructed from the complete genomes of Homo sapiens (hsa) and E. coli (eco). Here the global
metabolic pathway map (map01100) and the terpenoid backbone biosynthesis map (map00900) are shown, where human-speciﬁc pathways are
colored in green, E. coli speciﬁc pathways in pink, and shared pathways in blue or split coloring.
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.com/), is an ongoing project.
Accessing KEGG
KEGG is made available at both the GenomeNet website
(http://www.genome.jp/kegg/) and the KEGG website
(http://www.kegg.jp/). The GenomeNet site has been the
primary site, but this will change at the end of 2011.
The KEGG site will then be the primary site handling
all database update procedures, and the GenomeNet site
will become a mirror site.
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